Certified by Founder
Lodge
Relief Cardiovascular
start up
United States
- Costa Mesa, CA
- 09/01/2025
- Series A
- $12,000,000
Relief Cardiovascular, an inQB8 Medical Technologies portfolio company, is creating a novel smart implant to decongest heart failure patients.
The Relief System is the world’s first transcatheter implant to both monitor and modulate renal vein pressures, offering a novel solution for managing fluid in heart failure patients – particularly for the millions of heart failure patients with diuretic resistance.
- Industry Medical Equipment Manufacturing
- Website https://www.reliefcardio.com/
- LinkedIn https://www.linkedin.com/company/relief-cardiovascular/
WealthAi | $1,000,000 | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
Mesh Security | $12,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Co-reactive | $7,754,157 | (Jan 30, 2026)
Arkero | $6,000,000 | (Jan 30, 2026)
Redwood Materials | $425,000,000 | (Jan 30, 2026)
Twogee Biotech | $2,575,886 | (Jan 30, 2026)
Levellr | $2,500,000 | (Jan 30, 2026)
Indigo(1) | $50,000,000 | (Jan 30, 2026)
heyData | $16,500,000 | (Jan 30, 2026)